Global Pharmaceuticals & Biotech Big Green Snowflakes

Lukas Biomedical

Market Cap: NT$1.0b

Engages in the wholesale and retail of cosmetics in Taiwan.

GL Pharm Tech

Market Cap: ₩86.1b

Provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea.

Brii Biosciences

Market Cap: HK$1.5b

Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.

ACRO Biomedical

Market Cap: NT$4.6b

Develops medical-grade regenerative biomaterials.

Cann Group

Market Cap: AU$6.5m

Engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe.

Shandong Sinobioway Biomedicine

Market Cap: CN¥5.2b

Shandong Sinobioway Biomedicine Co., Ltd.

Novoprotein Scientific

Market Cap: CN¥3.0b

Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.

Zhejiang Shengda Bio-Pharm

Market Cap: CN¥3.4b

Develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry.

Sunshine Lake Pharma

Market Cap: HK$26.6b

Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

PegBio

Market Cap: HK$14.5b

A biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China.

Guangzhou Innogen Pharmaceutical Group

Market Cap: HK$20.2b

Engages in development of drugs.

Duality Biotherapeutics

Market Cap: HK$38.1b

A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

NIBEC

Market Cap: ₩290.6b

A healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

AdAlta

Market Cap: AU$4.6m

A clinical-stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.

curacleltd

Market Cap: ₩79.0b

Curacle Co., Ltd., a bio-venture business, engages in the research and development of drugs for diseases caused by aging process and damage to blood vessels.

Genomictree

Market Cap: ₩524.8b

A biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases.

TaiRx

Market Cap: NT$2.8b

Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.

Medigen Vaccine Biologics

Market Cap: NT$12.8b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

Organoidsciences

Market Cap: ₩236.6b

Develops regenerative therapies in South Korea.

Y.B Urban Renewal - Residential Development

Market Cap: ₪28.5m

Engages in the cultivation and production of medical cannabis.

Idorsia

Market Cap: CHF 728.4m

A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, and Canada.

Lifecore Biomedical

Market Cap: US$271.6m

Operates as an integrated contract development and manufacturing organization in the United States.

Valerio Therapeutics Société anonyme

Market Cap: €10.9m

A clinical-stage biotechnology company, designs and develops novel and first-in-class DNA-decoy therapies targeting proteins in tumors and inflammatory disease processes.

Prime Medicine

Market Cap: US$540.1m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

Appili Therapeutics

Market Cap: CA$1.8m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

Syros Pharmaceuticals

Market Cap: US$29.5k

A biopharmaceutical company, focuses on the development of treatment for hematologic malignancies.

Zeo ScientifiX

Market Cap: US$9.9m

A clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines.

PEPTONIC medical

Market Cap: €560.2m

A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.

BioAge Labs

Market Cap: US$178.5m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret

Market Cap: ₺2.7b

A biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey.

NFL Biosciences

Market Cap: €16.3m

A biotechnology company, engages in the development of botanical drugs in France.

Adimmune

Market Cap: NT$8.0b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Oncolys BioPharma

Market Cap: JP¥15.5b

Engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States.

Beijing Leadman BiochemistryLtd

Market Cap: CN¥4.4b

Researches and developss, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People’s Republic of China.

Taiwan Advance Bio-Pharmaceutical

Market Cap: NT$1.5b

Operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.

Pharos iBio

Market Cap: ₩77.9b

Develops treatments for rare and refractory diseases using AI based drug development platform in South Korea.